ISL
REPL icon

Ingalls & Snyder LLC’s Replimune Group REPL Stock Holding History

Ingalls & Snyder LLC’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111K Buy
+10,000
New +$61.2K ﹤0.01% 453

Other funds holding REPL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
RCI
Ridgeback Capital Investments Miami Beach, Florida $80.9M AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Ingalls & Snyder LLC's REPL Position: Q2 2026 in Review

Ingalls & Snyder LLC opened a new position in Replimune Group (REPL) in Q2 2026: 3,000 shares worth $33K. The stake represents ﹤0.01% of the portfolio and ranks #471 among its holdings.

199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Ingalls & Snyder LLC held 3,000 shares of Replimune Group worth $33K as of Q2 2026.
  • Replimune Group was a new Ingalls & Snyder LLC position in Q2 2026.
  • Replimune Group made up ﹤0.01% of Ingalls & Snyder LLC's portfolio in Q2 2026, its #471 holding.
  • 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Ingalls & Snyder LLC's 13F filing for Q2 2026, filed 14 Aug 2026.